Intravenous Infusions Plc (GHSE:IIL)

Ghana flag Ghana · Delayed Price · Currency is GHS
0.0500
0.00 (0.00%)
At close: Feb 16, 2026
0.00%
Market Cap 13.72M
Revenue (ttm) 9.30M
Net Income (ttm) -5.18M
Shares Out 274.41M
EPS (ttm) -0.02
PE Ratio n/a
Forward PE n/a
Dividend 0.00 (5.60%)
Ex-Dividend Date n/a
Volume 197,317
Average Volume 40,541
Open 0.0500
Previous Close n/a
Day's Range 0.0500 - 0.0500
52-Week Range 0.0400 - 0.0500
Beta 0.16
RSI 54.61
Earnings Date Jun 10, 2026

About Intravenous Infusions

Intravenous Infusions Plc, a pharmaceutical company, engages in the manufacturing and marketing of intravenous infusions and small volume injectables for therapeutic purposes in Ghana and the West African sub-region. It offers pethidine, including Chloroquine Phosphate and quinine dihydrochloride injections. The company was incorporated in 1969 and is based in Koforidua, Ghana. [Read more]

Industry Pharmaceutical Preparations
Founded 1969
Country Ghana
Stock Exchange Ghana Stock Exchange
Ticker Symbol IIL
Full Company Profile

Financial Performance

In 2025, Intravenous Infusions's revenue was 9.30 million, a decrease of -62.69% compared to the previous year's 24.94 million. Losses were -5.18 million, 706.0% more than in 2024.

Financial Statements

News

There is no news available yet.